Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway

Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway

Fan Yang,1,* Huan-Huan Liu,2,* Lei Zhang,1,* Xiao-Lu Zhang,1 Jie Zhang,1 Feng Li,1 Ning Zhao,2 Zhi-Yuan Zhang,1 Qi Kong,1 Xiao-Yu Liu,1 Ying Wu,1 Zhi-Ming Yu,1 Ling-Ling Qian,1 Ru-Xing Wang1,2 1Department of Cardiology, the Affiliated Wuxi People’s Hospital of Nanjing Medical...

Full description

Bibliographic Details
Main Authors: Yang F, Liu HH, Zhang L, Zhang XL, Zhang J, Li F, Zhao N, Zhang ZY, Kong Q, Liu XY, Wu Y, Yu ZM, Qian LL, Wang RX
Format: Article
Language:English
Published: Dove Medical Press 2023-10-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
diabetes
atrial fibrillation
advanced glycosylation end products
adenosine 5’-monophosphate-actived protein kinase
connexin
Online Access:https://www.dovepress.com/advanced-glycation-end-products-downregulate-connexin-43-and-connexin--peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/advanced-glycation-end-products-downregulate-connexin-43-and-connexin--peer-reviewed-fulltext-article-DMSO

Similar Items